• 20

    4 月

    2021

    Aptar CSP Technologies Earns ISO Quality Certifications for Medical Device Production

    Certification affirms the company’s quality [...]

  • 15

    2 月

    2021

    Aptar’s Activ-Film™ Technology Selected to Protect New SARS Rapid Antigen Test for COVID-19 Diagnosis

    Crystal Lake, Illinois, February 15, [...]

  • 16

    12 月

    2020

    Aptar CSP Technologies Increases Capacity for Active Packaging Solutions that Protect Diagnostic Test Kits

    Patented 3-Phase Activ-Polymer™ platform technology [...]

  • 06

    11 月

    2020

    Probiotics Packaging Feature Article Published in Nutritional Outlook

    Two of the most critical [...]

  • 19

    5 月

    2020

    Aptar Submits Application for Emergency Use Authorization to the German Regulatory Agency BfArM for ActivShield™ FFP2 Decontamination System

    Crystal Lake, Illinois, May 8, [...]

  • 03

    4 月

    2020

    Aptar Requests U.S. FDA Emergency Use Authorization for ActivShield™ N95 Filtering Facepiece Respirator Decontamination System

    Crystal Lake, Illinois, April 3, [...]

  • 29

    1 月

    2020

    Aptar CSP Launches Fully-Integrated Active Packaging Solution Combining Moisture Adsorption and Oxygen Scavenging Properties

    New oxygen scavenging and moisture [...]

  • 04

    11 月

    2019

    Aptar CSP Launches Xcelerate Development Services to Fast-Track Active Packaging Solutions

    From stability challenge to commercial [...]

  • 29

    10 月

    2019

    Aptar’s Activ-Blister™ Packaging Solution Approved by U.S. FDA for Oral Solid Dose HIV Prevention Medicine

    Aptar announces first FDA approval [...]